Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM7D5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,034
Award facts
- Contract value 100% obligated
- $20,034.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,034 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with a completion date of December 18, 2025. This non-set-aside award represents a single delivery transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication indicated for weight management, reflecting the Defense Health Agency's pharmaceutical supply requirements for military beneficiaries and related federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor within the federal medical procurement framework. The company's SPE2DX prime IDV functions as a comprehensive global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order exemplifies AmerisourceBergen's role as a key provider within the DLA's pharmaceutical distribution network, supporting the agency's mission to supply medications and medical commodities to Defense and Veterans Affairs healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM7D5?
SPE2DR26FM7D5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FM7D5 worth?
The government has obligated $20,034 on SPE2DR26FM7D5.
Is contract SPE2DR26FM7D5 an order under another contract?
Yes. SPE2DR26FM7D5 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM7D5 competed?
The extent of competition for SPE2DR26FM7D5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award